---
title: 'Follow-up: A Bayesian Perspective on the FDA Guidelines for Adaptive Clinical
  Trials'
date: '2020-02-13'
linkTitle: https://www.bayesianspectacles.org/follow-up-a-bayesian-perspective-on-the-fda-guidelines-for-adaptive-clinical-trials/
source: Bayesian Spectacles
description: In September 2018, the American Food and Drug Administration (FDA) issued
  a draft version of the industry guidance on “Adaptive Designs for Clinical Trials
  of Drugs and Biologics”. In an earlier blog post we provided some comments from
  a Bayesian perspective that we also submitted as feedback to the FDA. Two months
  ago, the FDA ...
disable_comments: true
---
In September 2018, the American Food and Drug Administration (FDA) issued a draft version of the industry guidance on “Adaptive Designs for Clinical Trials of Drugs and Biologics”. In an earlier blog post we provided some comments from a Bayesian perspective that we also submitted as feedback to the FDA. Two months ago, the FDA ...